Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Transdermal Patch in Tic Disorders and Tourette Syndrome
CTR20132216Phase 4Active
- Sponsor
- Shanxi Ruifulai Pharmaceutical
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clonidine in Provisional Tic Disorder (PTD), chronic tic disorder, Tourette syndrome (TS), sponsored by Shanxi Ruifulai Pharmaceutical. Started Jun 2015; status: active.
02
Drugs
clonidine
03
Conditions
Provisional Tic Disorder (PTD)chronic tic disorderTourette syndrome (TS)
Beyond the preview
Go deeper on CTR20132216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132216.